1,258
Views
2
CrossRef citations to date
0
Altmetric
Technical Report

Cross species application of quantitative neuropathology assays developed for clinical Alzheimer’s disease samples

ORCID Icon, , , , , , , , , , ORCID Icon & show all
Article: 1657768 | Received 12 Jun 2019, Accepted 16 Aug 2019, Published online: 03 Sep 2019

References

  • A. Alzheimer's. Alzheimer's disease facts and figures, Alzheimer's & dementia: the journal of the Alzheimer's Association. 2016; 12 (2016): 459–509.
  • Hyman BT, Phelps CH, Beach TG, et al. National institute on aging-Alzheimer’s association guidelines for the neuropathologic assessment of Alzheimer’s disease. Alzheimers Dement. 2012;8(1):1–6.
  • Keene CD, Darvas M, Kraemer B, et al. Neuropathological assessment and validation of mouse models for Alzheimer’s disease: applying NIA-AA guidelines. Pathobiol Aging Age Relat Dis. 2016;6:32397.
  • Keene CD,  Wilson AM, Kilgore MD et al. Luminex-based quantification of Alzheimer's disease neuropathologic change in formalin-fixed post-mortem human brain tissue. Lab. Invest. 2019; 99(7): 1056–1067.
  • Jankowsky JL, Fadale DJ, Anderson J, et al. Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase. Hum Mol Genet. 2004;13(2):159–170.
  • Fonte V, Dostal V, Roberts CM, et al. A glycine zipper motif mediates the formation of toxic beta-amyloid oligomers in vitro and in vivo. Mol Neurodegener. 2011;6(1):61.
  • Wittmann CW, Wszolek MF, Shulman JM, et al. Tauopathy in Drosophila: neurodegeneration without neurofibrillary tangles. Science. 2001;293(5530):711–714.
  • Finelli A, Kelkar A, Song H-J, et al. A model for studying Alzheimer’s Abeta42-induced toxicity in Drosophila melanogaster. Mol Cell Neurosci. 2004;26(3):365–375.
  • Yoshiyama Y, Higuchi M, Zhang B, et al. Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model. Neuron. 2007;53(3):337–351.
  • Kraemer BC, Zhang B, Leverenz JB, et al. Neurodegeneration and defective neurotransmission in a Caenorhabditis elegans model of tauopathy. Proc Natl Acad Sci U S A. 2003;100(17):9980–9985.
  • Taylor LM, McMillan PJ, Liachko NF, et al. Pathological phosphorylation of tau and TDP-43 by TTBK1 and TTBK2 drives neurodegeneration. Mol Neurodegener. 2018;13(1):7.
  • Latimer CS, Shively CA, Keene CD, et al. A nonhuman primate model of early Alzheimer’s disease pathologic change: Implications for disease pathogenesis. Alzheimers Dement. 2019;15(1):93–105.
  • Schmidt F, Boltze J, Jäger C, et al. detection and quantification of beta-amyloid, pyroglutamyl Abeta, and Tau in aged canines. J Neuropathol Exp Neurol. 2015;74(9):912–923.
  • Smolek T, Madari A, Farbakova J, et al. Tau hyperphosphorylation in synaptosomes and neuroinflammation are associated with canine cognitive impairment. J Comp Neurol. 2016;524(4):874–895.
  • Yu C-H, Song G-S, Yhee J-Y, et al. Histopathological and immunohistochemical comparison of the brain of human patients with Alzheimer’s disease and the brain of aged dogs with cognitive dysfunction. J Comp Pathol. 2011;145(1):45–58.
  • Wegiel J, Wisniewski HM, Soltysiak Z. Region- and cell-type-specific pattern of tau phosphorylation in dog brain. Brain Res. 1998;802(1–2):259–266.
  • Schütt T, Helboe L, Pedersen LØ, et al. Dogs with cognitive dysfunction as a spontaneous model for early Alzheimer’s disease: a translational study of neuropathological and inflammatory markers. J Alzheimers Dis. 2016;52(2):433–449.
  • Walker LC, Jucker M. The exceptional vulnerability of humans to Alzheimer’s disease. Trends Mol Med. 2017;23(6):534–545.
  • Sharma G, Huo A, Kimura T, et al. Tau isoform expression and phosphorylation in marmoset brains. J Biol Chem. 2019;294(30):11433–11444.
  • Chambers JK, Tokuda T, Uchida K, et al. The domestic cat as a natural animal model of Alzheimer’s disease. Acta Neuropathol Commun. 2015;3:78.